BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 12520739)

  • 1. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer].
    Fan YF; Huang ZH; Nie J
    Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Anticancer Res; 2000; 20(1C):601-4. PubMed ID: 10769702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].
    Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
    Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
    Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
    J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo.
    Fan YF; Huang ZH
    World J Gastroenterol; 2002 Oct; 8(5):853-6. PubMed ID: 12378629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor effect of angiogenesis inhibitor TNP-470 and 5-FU combined therapy on human gastric cancer xenograft.
    Nishimura K; Ohno M; Chung-Kang C; Kuroda Y
    Hepatogastroenterology; 2008; 55(82-83):774-8. PubMed ID: 18613452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
    Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
    Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.
    Lund EL; Bastholm L; Kristjansen PE
    Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470.
    Tanaka T; Konno H; Matsuda I; Nakamura S; Baba S
    Cancer Res; 1995 Feb; 55(4):836-9. PubMed ID: 7531615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of angiogenesis inhibitor TNP-470 with cytotoxic drugs in experimental therapy of nasopharyngeal carcinoma.
    Qian CN; Min HQ; Lin HL; Hong MH
    Ann Otol Rhinol Laryngol; 2000 Jul; 109(7):641-5. PubMed ID: 10903044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo.
    Ogawa H; Sato Y; Kondo M; Takahashi N; Oshima T; Sasaki F; Une Y; Nishihira J; Todo S
    Oncol Rep; 2000; 7(3):467-72. PubMed ID: 10767353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
    Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental therapy with angiogenesis inhibitor TNP-470 on human ovarian cancer transplanted subcutaniously in nude mice].
    Kong H; Jin Z; Yao M
    Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):556-8. PubMed ID: 12411020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
    Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
    Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
    Naganuma Y; Choijamts B; Shirota K; Nakajima K; Ogata S; Miyamoto S; Kawarabayashi T; Emoto M
    Cancer Sci; 2011 Aug; 102(8):1545-52. PubMed ID: 21631643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.